glp 1 oral novo nordisk stock soars after FDA approves first GLP-1 for weight loss By World Pharma Today | 🎉

Pregnant or breastfeeding individuals, and anyone with a history of seizures or active cancer, should consult a provider before considering it

Together, they create an environment where fat loss is prioritized without sacrificing lean tissue or metabolic efficiency

Switching to the KD well in advance of pregnancy would be much safer, as this timing would not expose mother or the developing baby to the stress of the keto-adaptation period

It determines which peptide is appropriate for a given research context, how well it is tolerated over sustained use, and whether its off-target effects are a liability or a feature